Key Points
- Director Steven Voskuil bought 20,000 shares on Nov. 21 at $15.04 each for a total of $300,800, boosting his stake 143.63% to 33,925 shares (valued ~ $510,232).
- Bath & Body Works missed the quarter with $0.35 EPS vs. $0.40 expected and $1.59B revenue vs. $1.64B expected (revenue down 1% YoY), set FY2025 and Q4 2025 guidance, and holds an average analyst rating of "Hold" with a $26.84 target.
- The company declared a quarterly dividend of $0.20 (annualized $0.80) with an ex-dividend date of Nov. 21 and payment on Dec. 5, implying a ~5.1% yield.
Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) Director Lucy Brady acquired 3,470 shares of the company's stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $14.40 per share, for a total transaction of $49,968.00. Following the purchase, the director directly owned 17,482 shares of the company's stock, valued at $251,740.80. This represents a 24.76% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link.
Bath & Body Works Stock Performance
Shares of NYSE BBWI opened at $15.58 on Tuesday. The company has a 50 day simple moving average of $24.37 and a two-hundred day simple moving average of $28.00. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of 4.62, a P/E/G ratio of 0.86 and a beta of 1.53.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 earnings per share. The business's revenue for the quarter was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 5.1%. Bath & Body Works's dividend payout ratio (DPR) is presently 24.62%.
Analyst Upgrades and Downgrades
BBWI has been the topic of a number of analyst reports. Raymond James Financial reiterated a "market perform" rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. UBS Group decreased their target price on shares of Bath & Body Works from $32.00 to $17.00 and set a "neutral" rating for the company in a report on Friday. JPMorgan Chase & Co. cut their price target on shares of Bath & Body Works from $26.00 to $15.00 and set a "neutral" rating on the stock in a report on Thursday, November 20th. Weiss Ratings reissued a "hold (c-)" rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company lowered their price objective on Bath & Body Works from $33.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $26.84.
View Our Latest Report on Bath & Body Works
Institutional Investors Weigh In On Bath & Body Works
A number of large investors have recently added to or reduced their stakes in BBWI. First Horizon Corp bought a new position in shares of Bath & Body Works during the 3rd quarter valued at $29,000. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in shares of Bath & Body Works in the second quarter worth $33,000. SVB Wealth LLC purchased a new stake in Bath & Body Works during the first quarter valued at $35,000. Geneos Wealth Management Inc. lifted its holdings in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after acquiring an additional 801 shares during the period. Finally, Parallel Advisors LLC boosted its position in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after purchasing an additional 481 shares during the last quarter. Institutional investors own 95.14% of the company's stock.
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
